What PathAI Added in the AISight Dx v2.21 Release
PathAI announced the AISight Dx version 2.21 release on July 28, 2026. The release adds a customizable Case Assignments Dashboard with a My Cases by AI Impression widget that shows live bar charts for case prioritization, plus slide viewer changes including bulk annotation deletion, editable linear measurements and a motion-based rotation mode. It also adds faster colleague invitations with online status indicators, bulk ingestion supporting Specimen, Block ID and Slide ID fields, clinician preference management in a new Library tab, and archiving to Glacier Deep Archive with on-demand restoration. The announcement states that AISight Dx is FDA-cleared for primary diagnosis in the United States and CE-IVD marked for primary diagnosis in the European Economic Area, the United Kingdom and Switzerland.
Why the PathAI v2.21 Storage and Dashboard Changes Matter to Labs
Release notes rarely matter, and then one line does. Deep archive storage with restore on demand is the quiet admission that whole slide images break lab budgets, and a lab planning full digital sign out should price that before it signs. The dashboard sorting cases by AI impression is more interesting than it looks, because the order a pathologist works in starts being set by the software, and nobody has settled who is accountable when that order is wrong.
Where the PathAI Update Comes From
PathAI is the original record behind this update. It tells us what the company published. This brief adds the market context and the method we would use to test the development against other evidence.
How We Would Research the PathAI AISight Dx v2.21 Release
The source gives us the starting point. This is how we would build the next layer of research around it.
- We would start with the real cost of deep archive storage and, more importantly, how long a restore takes when a case is needed back.
- Then we would ask whether sorting cases by AI impression can be turned off, and whether the original order is kept on record.
- We would confirm which AI applications in the platform are cleared and which are research use only, since the release notes mix them.